Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs)
Status:
NOT_YET_RECRUITING
Trial end date:
2026-11-20
Target enrollment:
Participant gender:
Summary
To evaluate the additional efficacy and safety of oral enterobacterial capsules in patients with intermediate and advanced liver cancer and treated with tyrosine kinase inhibitors (TKIs) combined with immunotherapy.